Old Mission Capital’s DexCom DXCM Stock Holding History

Old Mission Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,900	Closed	-$801K	–	459
2020 Q2	$801K	Buy	+7,900	New	+$707K	0.06%	220

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Old Mission Capital's DXCM Position: Q3 2020 in Review

Old Mission Capital sold out of DexCom (DXCM) in Q3 2020, closing a stake of 7,900 shares — an estimated $801K sold.

Old Mission Capital first reported a position in DXCM in Q2 2020 and held it in 1 quarter. The position peaked at $801K in Q2 2020. 727 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

Old Mission Capital reported no remaining DexCom position as of Q3 2020 after selling out during the quarter.
Old Mission Capital sold 7,900 DexCom shares in Q3 2020, an estimated $801K.
Old Mission Capital first reported a position in DexCom in Q2 2020 and held it in 1 quarter.
Old Mission Capital's DexCom position peaked at $801K in Q2 2020.
727 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Old Mission Capital's 13F filing for Q3 2020, filed 16 Nov 2020.